Matters of Survival

Is better HIV treatment related to improved survival after an individual is diagnosed with an AIDS-defining opportunistic illness (AIDS-OI)? That was one of the...

Undetectable = Untransmittable Reconfirmed by New Study, Embraced at IAS 2017

A newly completed study of 358 serodiscordant gay couples has not found a single case of HIV transmission in 16,889 acts of condomless anal...

Building Success

When it comes to Effective HIV reform, don’t throw the baby out with the bathwater by Mariel Selbovitz, MPH, and Leslie G Selbovitz, MD LifeGuide Extensive progress in...

Treatment as Prevention

LifeGuide A community perspective on PrEP delves into its pros & cons by Jeannie Gibbs Post-exposure prophylaxis (PrEP) is the provision of antiretrovirals (ARVs) to HIV-negative...

Janssen Announces FDA Approval of SYMTUZA

The Janssen Pharmaceutical Companies of Johnson & Johnson announced on July 18, 2018 that the U.S. FDA has approved the use of SYMTUZA, the...

Women’s HIV Program: Empowerment Is Treatment

Undetectable is a worthy goal, no doubt about it. A suppressed viral load very often means the individual living with HIV is adherent to...

A Shot in the Dark

Therapeutic Vaccine Research Toward a Functional Cure Shows Promise by Jeannie Wraight Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...

The Road Ahead

LifeGuide Treatment Horizons The Road Ahead New candidates hold promise for ARV therapy & therapeutic vaccines by Mariel Selbovitz, MPH The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy...

Old Concept, New Hope

LifeGuide Therapeutic Vaccines May Change the Treatment Landscape for the Better by Jeannie Gibbs Clinical development of HIV therapeutic vaccine candidate, Vacc-4x, will continue after further...

Alisson Sombredero, MD

Not So Complicated Alisson Sombredero, MD, offers to physicians compelling approaches to HIV care by Chael Needle Alisson Sombredero, MD, is more than two months into her...

LATEST POSTS

Jonathan & Derrick Allen-Young: Advocates

Someone once sang, Love is a many splendored thing. Well, it seems it applies to these two doves. Twenty-seven year old Jonathan Allen and twenty-five...

John Wikiera: Advocate

PrEP Factors